Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children’s Oncology Group-Reference-Cited by-同舟云学术

Shortened intensified multi-agent chemotherapy and non-cross resistant maintenance therapy for advanced lymphoblastic lymphoma in children and adolescents: report from the Children’s Oncology Group

Published:2008-10 Issue:2 Volume:143 Page:261-267
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Abromowitch Minnie,Sposto Richard,Perkins Sherrie,Zwick David,Siegel Stuart,Finlay Jonathan,Cairo Mitchell S.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2008.07320.x/fullpdf

Reference20 articles.

1. Childhood non-Hodgkin’s lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2);Anderson;New England Journal of Medicine,1983

2. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin’s lymphoma: a report of CCG-551 from the Childrens Cancer Group;Anderson;Journal of Clinical Oncology,1993

3. Childhood T-cell lymphoblastic lymphoma (TLL) results of the SFOP LMT96 strategy;Bergeron;Pediatric Blood & Cancer,2006

4. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma;Burkhardt;Journal of Clinical Oncology,2006

5. Clinical and biological significance of loss of heterozygosity at chromosome 6q in children and adolescents with T-cell lymphoblastic lymphoma;Burkhardt;Pediatric Blood & Cancer,2006

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD99 tumor associated antigen is a potential target for antibody therapy of T-cell acute lymphoblastic leukemia;Exploration of Targeted Anti-tumor Therapy;2024-02-19

2. Diagnosis and management of lymphoblastic lymphoma in children, adolescents and young adults;Best Practice & Research Clinical Haematology;2023-03

3. Staging for Childhood Cancer Management;Pediatric Surgical Oncology;2023

4. Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell lymphoblastic lymphoma;Blood Science;2022-07

5. Design of a targeted next‐generation DNA sequencing panel for pediatric T‐cell lymphoblastic lymphoma to unravel biology and optimize treatment;Genes, Chromosomes and Cancer;2022-03-23